A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial (Q35012981)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial |
scientific article |
Statements
1 reference
A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial (English)
1 reference
K U Ulbricht
1 reference
G M Behrens
1 reference
M Stoll
1 reference
B Salzberger
1 reference
H Jessen
1 reference
A B Jessen
1 reference
B Kuhlmann
1 reference
A Trein
1 reference
R E Schmidt
1 reference
H Heiken
1 reference
22 April 2011
1 reference
1 reference
5
1 reference
44-50
1 reference
Identifiers
1 reference
1 reference
1 reference